ECEL1
Basic information
Region (hg38): 2:232479827-232487834
Links
Phenotypes
GenCC
Source:
- distal arthrogryposis type 5D (Definitive), mode of inheritance: AR
- distal arthrogryposis type 5D (Strong), mode of inheritance: AR
- distal arthrogryposis type 5D (Strong), mode of inheritance: AR
- distal arthrogryposis type 5D (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Arthrogryposis, distal, type 5D | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal | 23236030; 23261301; 25099528 |
ClinVar
This is a list of variants' phenotypes submitted to
- Distal arthrogryposis type 5D (16 variants)
- not provided (8 variants)
- See cases (2 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ECEL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 29 | ||||
missense | 58 | 79 | ||||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 10 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 1 | 1 | 4 | 1 | 7 | |
non coding | 12 | 22 | 34 | |||
Total | 21 | 13 | 59 | 46 | 28 |
Highest pathogenic variant AF is 0.000138
Variants in ECEL1
This is a list of pathogenic ClinVar variants found in the ECEL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-232480018-G-C | Benign (Nov 11, 2018) | |||
2-232480086-T-A | Likely benign (Nov 14, 2019) | |||
2-232480161-C-T | Inborn genetic diseases • Distal arthrogryposis type 5D | Uncertain significance (May 06, 2024) | ||
2-232480167-A-G | Distal arthrogryposis type 5D | Uncertain significance (Mar 12, 2024) | ||
2-232480170-T-C | Inborn genetic diseases | Uncertain significance (Aug 02, 2021) | ||
2-232480184-A-G | Inborn genetic diseases | Uncertain significance (Aug 04, 2023) | ||
2-232480192-G-C | Inborn genetic diseases | Uncertain significance (May 20, 2024) | ||
2-232480202-C-A | Distal arthrogryposis type 5D | Uncertain significance (Jul 12, 2019) | ||
2-232480203-A-G | Distal arthrogryposis type 5D | Pathogenic (Apr 15, 2013) | ||
2-232480205-T-G | Uncertain significance (May 08, 2023) | |||
2-232480215-G-A | Inborn genetic diseases | Uncertain significance (Jan 19, 2022) | ||
2-232480239-C-A | Inborn genetic diseases | Uncertain significance (Jan 17, 2024) | ||
2-232480259-T-G | not specified | Conflicting classifications of pathogenicity (Mar 29, 2018) | ||
2-232480281-T-G | Distal arthrogryposis type 5D | Benign (Jul 30, 2021) | ||
2-232480395-A-T | ECEL1-related disorder | Likely benign (May 06, 2019) | ||
2-232480399-C-A | Arthrogryposis multiplex congenita | Uncertain significance (Apr 09, 2019) | ||
2-232480401-G-A | Likely benign (Jun 13, 2018) | |||
2-232480429-A-G | ECEL1-related disorder | Uncertain significance (Jul 17, 2023) | ||
2-232480452-C-T | Benign (Dec 31, 2019) | |||
2-232480456-C-T | Inborn genetic diseases | Uncertain significance (Aug 10, 2021) | ||
2-232480461-C-T | ECEL1-related disorder | Likely benign (Dec 31, 2019) | ||
2-232480539-C-A | Benign (Oct 02, 2019) | |||
2-232480539-C-T | Benign (Nov 11, 2018) | |||
2-232480716-A-G | Distal arthrogryposis type 5D | Likely pathogenic (May 04, 2020) | ||
2-232480716-A-T | Distal arthrogryposis type 5D | Pathogenic (Nov 16, 2017) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ECEL1 | protein_coding | protein_coding | ENST00000304546 | 17 | 8002 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.79e-13 | 0.984 | 125687 | 0 | 60 | 125747 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.478 | 409 | 437 | 0.936 | 0.0000256 | 4917 |
Missense in Polyphen | 137 | 161.04 | 0.85072 | 1884 | ||
Synonymous | -0.324 | 197 | 191 | 1.03 | 0.0000116 | 1538 |
Loss of Function | 2.46 | 27 | 44.8 | 0.603 | 0.00000256 | 444 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00150 | 0.00150 |
Ashkenazi Jewish | 0.0000998 | 0.0000992 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000178 | 0.000176 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May contribute to the degradation of peptide hormones and be involved in the inactivation of neuronal peptides.;
- Disease
- DISEASE: Arthrogryposis, distal, 5D (DA5D) [MIM:615065]: An autosomal recessive form of distal arthrogryposis, a disease characterized by congenital joint contractures that mainly involve two or more distal parts of the limbs, in the absence of a primary neurological or muscle disease. DA5D is characterized by severe camptodactyly of the hands, mild camptodactyly of the toes, clubfoot and/or a calcaneovalgus deformity, extension contractures of the knee, unilateral ptosis or ptosis that is more severe on one side, a round-shaped face, arched eyebrows, a bulbous upturned nose, and micrognathia. Patients do not have ophthalmoplegia. {ECO:0000269|PubMed:23236030, ECO:0000269|PubMed:23261301, ECO:0000269|PubMed:23808592, ECO:0000269|PubMed:23829171}. Note=The disease is caused by mutations affecting the gene represented in this entry. ECEL1 mutations have also been found in patients with arthrogryposis, significant ophthalmoplegia, and refractive errors (PubMed:23808592). {ECO:0000269|PubMed:23808592}.;
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.207
- rvis_EVS
- 0
- rvis_percentile_EVS
- 54.07
Haploinsufficiency Scores
- pHI
- 0.130
- hipred
- Y
- hipred_score
- 0.782
- ghis
- 0.404
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.362
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ecel1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- respiratory system process;proteolysis;neuropeptide signaling pathway
- Cellular component
- integral component of plasma membrane
- Molecular function
- metalloendopeptidase activity;metallopeptidase activity;metal ion binding